We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-11.97%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$10.6B
AUM Growth
-$1.52B
Cap. Flow
+$47.1M
Cap. Flow %
0.44%
Top 10 Hldgs %
18.51%
Holding
395
New
8
Increased
194
Reduced
112
Closed
28

Top Sells

Rank Stock Value
1
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$66.2M
2
MTB icon
M&T Bank
MTB
+$43.8M
3
BKR icon
Baker Hughes
BKR
+$38.3M
4
ORCL icon
Oracle
ORCL
+$36.5M
5
CDK
CDK Global, Inc.
CDK
+$35.6M

Sector Composition

Rank Sector Weight
1 Technology 19.35%
2 Healthcare 17.05%
3 Financials 15.67%
4 Industrials 13.84%
5 Consumer Discretionary 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRS icon
26
Northern Trust
NTRS
$22.4B
$85.1M 0.8%
881,964
+1,134
+0.1% +$120K
CMCSA icon
27
Comcast
CMCSA
$80.9B
$84.7M 0.8%
2,157,679
+39,842
+2% +$1.71M
DG icon
28
Dollar General
DG
$27.2B
$82.2M 0.78%
335,063
-475
-0.1% -$111K
TROW icon
29
T. Rowe Price
TROW
$25.5B
$81M 0.77%
713,277
+8,481
+1% +$1.08M
SYK icon
30
Stryker
SYK
$129B
$80.9M 0.76%
406,769
+126
+0% +$29.6K
ES icon
31
Eversource Energy
ES
$28.1B
$80.1M 0.76%
948,131
-13,988
-1% -$1.24M
APD icon
32
Air Products & Chemicals
APD
$65.2B
$79.1M 0.75%
328,936
+50,669
+18% +$12.3M
DOC
33
DELISTED
PHYSICIANS REALTY TRUST
DOC
$78.9M 0.75%
4,520,719
+88,058
+2% +$1.55M
HP icon
34
Helmerich & Payne
HP
$3.36B
$77.9M 0.74%
1,809,982
-167,712
-8% -$7.79M
CB icon
35
Chubb
CB
$139B
$75.8M 0.72%
385,762
+3,553
+0.9% +$732K
FLO icon
36
Flowers Foods
FLO
$1.62B
$75.6M 0.71%
2,871,103
+34,802
+1% +$916K
EWBC icon
37
East-West Bancorp
EWBC
$17.8B
$75.2M 0.71%
1,159,997
+57,522
+5% +$4.13M
COO icon
38
Cooper Companies
COO
$13.7B
$73.4M 0.69%
938,256
+70,256
+8% +$6.22M
MRK icon
39
Merck
MRK
$323B
$73.3M 0.69%
804,492
-14,423
-2% -$1.28M
COP icon
40
ConocoPhillips
COP
$141B
$72.3M 0.68%
804,839
-85,155
-10% -$8.77M
UMBF icon
41
UMB Financial
UMBF
$10.7B
$71.9M 0.68%
835,500
+12,904
+2% +$1.17M
PRGS icon
42
Progress Software
PRGS
$1.59B
$71.6M 0.68%
1,580,601
+176,432
+13% +$8.4M
COLM icon
43
Columbia Sportswear
COLM
$3.25B
$71.5M 0.68%
998,765
+33,331
+3% +$2.66M
AIT icon
44
Applied Industrial Technologies
AIT
$12.9B
$69.9M 0.66%
726,748
+9,928
+1% +$1M
CHH icon
45
Choice Hotels
CHH
$5.15B
$67M 0.63%
600,156
+9,008
+2% +$1.17M
MAS icon
46
Masco
MAS
$16.4B
$66.5M 0.63%
1,314,304
+13,369
+1% +$707K
OGS icon
47
ONE Gas
OGS
$5.02B
$66.2M 0.63%
815,573
+13,097
+2% +$1.12M
ROST icon
48
Ross Stores
ROST
$78.1B
$64.5M 0.61%
918,499
+15,600
+2% +$1.39M
CSCO icon
49
Cisco
CSCO
$452B
$63.4M 0.6%
1,485,779
-10,859
-0.7% -$520K
XOM icon
50
ExxonMobil
XOM
$642B
$63.3M 0.6%
739,478
+76,792
+12% +$6.93M

Similar funds

Boston Trust Walden's Q2 2022 Portfolio in Review

As of Q2 2022, Boston Trust Walden held 395 positions worth $10.6B, down 13% from $12.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden's Q2 2022 filing shows 8 new, 194 increased, 112 reduced and 28 closed positions. Its largest new stake was Core Laboratories: 1,993,528 shares worth $39.5M. The largest sale was ASPEN TECHNOLOGY INC, an estimated $66.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Boston Trust Walden's largest Q2 2022 buy was Core Laboratories: 1,993,528 shares worth $39.5M.
  • Boston Trust Walden added most to Americold in Q2 2022, an estimated $32.5M increase.
  • Boston Trust Walden's biggest Q2 2022 reduction was M&T Bank, cutting an estimated $43.8M.
  • Boston Trust Walden fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $66.2M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $10.6B portfolio in Q2 2022.
  • Boston Trust Walden opened 8 new positions and closed 28 in Q2 2022.
  • Boston Trust Walden's portfolio value fell 13% quarter-over-quarter to $10.6B.

Based on Boston Trust Walden's 13F filing for Q2 2022, filed 22 Jul 2022.